These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients. Klietz M; Greten S; Wegner F; Höglinger GU Drugs Aging; 2019 Jun; 36(6):511-530. PubMed ID: 30937878 [TBL] [Abstract][Full Text] [Related]
4. Long-term effectiveness and quality of life improvement in entacapone-treated Parkinson's disease patients: the effects of an early therapeutic intervention. Grandas F; Hernández B; Eur J Neurol; 2007 Mar; 14(3):282-9. PubMed ID: 17355548 [TBL] [Abstract][Full Text] [Related]
5. Medical management of levodopa-associated motor complications in patients with Parkinson's disease. Jankovic J; Stacy M CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819 [TBL] [Abstract][Full Text] [Related]
6. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
7. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa]. Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study. Durif F; Devaux I; Pere JJ; Delumeau JC; Bourdeix I; Eur Neurol; 2001; 45(2):111-8. PubMed ID: 11244274 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease. Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Adjuvant Treatment with Entacapone in Advanced Parkinson's Disease with Motor Fluctuation: A Systematic Meta-Analysis. Li J; Lou Z; Liu X; Sun Y; Chen J Eur Neurol; 2017; 78(3-4):143-153. PubMed ID: 28813703 [TBL] [Abstract][Full Text] [Related]
11. Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease. Malek NM; Grosset KA; Stewart D; Macphee GJ; Grosset DG Parkinsonism Relat Disord; 2013 Jun; 19(6):586-9. PubMed ID: 23522959 [TBL] [Abstract][Full Text] [Related]
12. Freezing of gait in patients with advanced Parkinson's disease. Giladi N; Treves TA; Simon ES; Shabtai H; Orlov Y; Kandinov B; Paleacu D; Korczyn AD J Neural Transm (Vienna); 2001; 108(1):53-61. PubMed ID: 11261746 [TBL] [Abstract][Full Text] [Related]
14. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Goetz CG; Stebbins GT; Blasucci LM Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412 [TBL] [Abstract][Full Text] [Related]
15. Drug safety profiles in geriatric patients with Parkinson's disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis. Greten S; Müller-Funogea JI; Wegner F; Höglinger GU; Simon N; Junius-Walker U; Gerbel S; Krause O; Klietz M J Neural Transm (Vienna); 2021 Jan; 128(1):49-60. PubMed ID: 33263172 [TBL] [Abstract][Full Text] [Related]
16. Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice. Ceballos-Baumann A; Häck HJ Curr Med Res Opin; 2011 Oct; 27(10):1899-905. PubMed ID: 21867400 [TBL] [Abstract][Full Text] [Related]
17. Prescribing patterns of antiparkinson drugs in a group of Colombian patients, 2015. Machado-Alba JE; Calvo-Torres LF; Gaviria-Mendoza A; Castrillón-Spitia JD Biomedica; 2018 Sep; 38(3):417-426. PubMed ID: 30335247 [TBL] [Abstract][Full Text] [Related]
18. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life. Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551 [TBL] [Abstract][Full Text] [Related]
19. Locomotor response to levodopa in fluctuating Parkinson's disease. Moore ST; MacDougall HG; Gracies JM; Ondo WG Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529 [TBL] [Abstract][Full Text] [Related]